Equity

3 Months Ended

Dec. 31, 2024

Equity [Abstract]

Equity

7. Equity

As of December 31, 2024, the Company had 101,000,000 (September 30,2024: 21,000,000) shares of all classes of capital stock, each with a par value of $0.0001 per share, authorized and available to issue for purposes of capital financing, consisting of (a) 80,000,000 (September 30,2024: 19,000,000) shares of class A common stock, (b) 20,000,000 (September 30,2024: 1,000,000) shares of class B common stock, and (c)1,000,000 (September 30,2024: 1,000,000) shares of preferred stock.

On June 6, 2023, a shareholder had subscribed for 100 shares of the Class B common stock of the Company, at a price of US$0.01 per share, an aggregate of US$1. The amount was received after the three months ended December 31, 2023, and was recorded as a subscription receivable as of December 31, 2023.

On September 29, 2023, shareholders had subscribed for a total of 999,900 shares of the Class B common stock of the Company, at a price of US$0.01 per share, an aggregate of US$9,999. The amount was received subsequent to the three months ended December 31, 2023, and was recorded as a subscription receivable as of December 31, 2023.

On October 8, 2024, the shareholders and Board of Directors of the Company approved a 20 for 1 forward stock split (the “Stock Split”) of the Company’s authorized, issued and outstanding shares of common stock, par value $0.0001. Each pre-split share of common stock outstanding was automatically converted into 20 new shares of common stock. The outstanding Class A and Class B Common Stock after the Stock Split were 600,000 shares and 19,400,000 shares, respectively.

In October 2024, the Company filed a Certificate of Amendment with the Office of the Secretary of State of Delaware to effective an increase in the Company’s authorized shares of capital stock to 101,000,000 shares each with a par value of $0.0001 per share, consisting of 80,000,000 shares of Class A Common Stock, 20,000,000 shares of Class B Common Stock and 1,000,000 shares of preferred stock.

As of December 31, 2024, the Company had 20,000,000 (September 30,2024: 1,000,000) issued and outstanding shares of common stock with total value of US$2,000 (September 30,2024: US$100) which was presented in the Group’s consolidated balance sheets. During the three months ended December 31, 2024 and 2023, no preferred stock was issued and outstanding.